AFC-HD AMS Life Science Co Ltd
TSE:2927
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
A
|
AFC-HD AMS Life Science Co Ltd
TSE:2927
|
13B JPY |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
208.7B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
116B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.7T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
36.6B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
38.7B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
22.8B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
921.5B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
AFC-HD AMS Life Science Co Ltd
Glance View
AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. The company is headquartered in Shizuoka-Shi, Shizuoka-Ken and currently employs 793 full-time employees. The company went IPO on 2005-03-03. The firm is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The firm operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The firm is also engaged in the management of restaurants through subsidiary.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for AFC-HD AMS Life Science Co Ltd is 4.6%, which is above its 3-year median of 4.4%.
Over the last 3 years, AFC-HD AMS Life Science Co Ltd’s Net Margin has increased from 3.2% to 4.6%. During this period, it reached a low of 3.2% on Nov 30, 2022 and a high of 5.3% on May 31, 2025.
